Manufacturing

Our solid manufacturing facility offers production capabilities across a wide range of products, supported by high capacity and a flexible manufacturing infrastructure. With our advanced production lines capable of simultaneously processing 1,000 kg of granules, producing 3 million tablets per hour, and 400,000 capsules per hour, the facility has an annual production capacity of 7.5 billion tablets and 1.2 billion capsules.

Solid Packaging

As part of our solid packaging operations, tablet, capsule, and powder products manufactured at our main production facility are packaged on 10 blister packaging lines, 2 bottle filling lines and 1 sachet filling line. With our fully integrated lines covering all stages from primary packaging to cartoning, 100% automated weight control, serialization/2D coding, security labeling, and case packing, we ensure the highest levels of product safety and traceability.

We manufacture the following solid dosage forms:

Our injectable ampoule and vial products are manufactured in aseptic production areas designed to meet the highest safety standards, using advanced manufacturing technologies and state-of-the-art equipment.

Our annual production capacity includes 14 million ampoules ranging from 1 mL to 10 mL and 9 million vials ranging from 2 mL to 100 mL, all manufactured under sterile conditions.

Cephalosporin Manufacturing

Cephalosporin products are manufactured in a fully segregated production facility, independent from our main manufacturing operations, ensuring complete operational separation. In addition to sterile cephalosporin products, the facility manufactures non-sterile solid dosage forms including tablets, film-coated tablets, capsules and oral suspensions. At our facility, we have an annual production capacity of 4 million units of suspensions and 5 million units of tablets/capsules for non-sterile cephalosporin products, and 8 million units of injectable vials for sterile cephalosporin products.